Suppr超能文献

美国 ISAT 时代后破裂与未破裂动脉瘤治疗趋势:全国住院患者样本分析。

Trends of Ruptured and Unruptured Aneurysms Treatment in the United States in Post-ISAT Era: A National Inpatient Sample Analysis.

机构信息

Neurosurgery Service Beth Israel Deaconess Medical CenterHarvard Medical School Boston MA.

Department of Medicine Beth Israel Deaconess Medical CenterHarvard Medical School Boston MA.

出版信息

J Am Heart Assoc. 2021 Feb 16;10(4):e016998. doi: 10.1161/JAHA.120.016998. Epub 2021 Feb 9.

Abstract

Background The ISAT (International Subarachnoid Aneurysm Trial) has generated a paradigm shift towards endovascular treatment for intracranial aneurysms but remains unclear if this has led to a true reduction in the risk for aneurysmal subarachnoid hemorrhage (aSAH). We sought to study the association between the treatment burden of unruptured and ruptured aneurysms in the post-ISAT era. Methods and Results Admissions data from the National Inpatient Sample (2004-2014) were extracted, including patients with a primary diagnosis of aSAH or unruptured intracranial aneurysms treated by clipping or coiling. Within each year, this combined group was randomly matched to non-aneurysmal control group, based on age, sex, and Elixhauser comorbidity index. Multinomial regression was performed to calculate the relative risk ratio of undergoing treatment for either ruptured or unruptured aneurysms in comparison with the reference control group, adjusted for time. After adjusting for National Inpatient Sample sampling effects, 243 754 patients with aneurysm were identified, 174 580 (71.6%) were women; mean age, 55.4±13.2 years. A total of 121 882 (50.01%) patients were treated for unruptured aneurysms, 79 627 (65.3%) endovascularly and 42 256 (34.7%) surgically. A total of 121 872 (49.99%) patients underwent procedures for aSAH, 68 921 (56.6%) endovascular, and 52 951 (43.5%) surgically. Multinomial regression revealed a significant year-to-year decrease in aSAH procedures compared with the control group of non-aneurysmal hospitalizations (relative risk ratio, 0.963 per year; <0.001), while there was no statistical significance for unruptured aneurysms procedures (relative risk ratio, 1.012 per year; =0.35). Conclusions With each passing year, there is a significant decrease in relative risk ratio of undergoing treatment for aSAH, concomitant with a stable annual risk of undergoing treatment for unruptured intracranial aneurysms.

摘要

背景

ISAT(国际蛛网膜下腔动脉瘤试验)引发了针对颅内动脉瘤的血管内治疗范式转变,但仍不清楚这是否导致了真正的蛛网膜下腔出血(aSAH)风险降低。我们试图研究 ISAT 后时代未破裂和破裂颅内动脉瘤的治疗负担之间的关联。

方法和结果

从国家住院患者样本(2004-2014 年)中提取了包括接受夹闭或线圈治疗的 aSAH 或未破裂颅内动脉瘤的患者的入院数据。在每年内,根据年龄、性别和 Elixhauser 合并症指数,将该联合组随机与非动脉瘤对照组相匹配。采用多项回归计算与参考对照组相比,接受破裂或未破裂动脉瘤治疗的相对风险比,同时调整时间因素。在调整国家住院患者样本抽样效果后,共确定了 243754 例动脉瘤患者,其中 174580 例(71.6%)为女性;平均年龄为 55.4±13.2 岁。共有 121882 例(50.01%)患者接受未破裂动脉瘤治疗,其中 79627 例(65.3%)采用血管内治疗,42256 例(34.7%)采用手术治疗。共有 121872 例(49.99%)患者接受 aSAH 治疗,其中 68921 例(56.6%)采用血管内治疗,52951 例(43.5%)采用手术治疗。多项回归显示,与非动脉瘤住院对照组相比,aSAH 治疗的年治疗率显著下降(相对风险比,每年 0.963;<0.001),而未破裂动脉瘤治疗的年治疗率无统计学意义(相对风险比,每年 1.012;=0.35)。

结论

随着时间的推移,接受 aSAH 治疗的相对风险比显著降低,而每年接受未破裂颅内动脉瘤治疗的风险保持稳定。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce2c/7955327/06bcc404092b/JAH3-10-e016998-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验